Chinese Firm Haiwen & Partners Poised to Disrupt Cross-Border Deals with Bold Strategy

In recent years, the landscape for cross-border deals involving Chinese companies has dwindled significantly. Beijing-based firm Haiwen & Partners is adopting a bold approach to tackle this head-on, with a long-term ambition to establish themselves as the premier lead counsel for China’s major cross-border deals, a role traditionally entrusted to U.S. or U.K. firms. This…

Read More

Cisco Evades $2.75 Billion Patent Infringement Claim Amid Judicial Recusal Controversy

Global tech behemoth, Cisco, breathed a sigh of relief earlier this week when a Virginia federal judge dismissed claims that the tech powerhouse infringed upon a smaller cybersecurity company’s software patents. This resolution follows a notable reversal of fortune from the initial judgement, which had favoured the cybersecurity start-up to the tune of $2.75 billion….

Read More

K&L Gates Reduces Associate Ranks Amid Record Revenue and Shifting Client Demand

According to multiple sources familiar with the firm, K&L Gates has recently reduced associate ranks in several major U.S. markets, including Chicago, Boston, Washington, and Pittsburgh. However, a representative for K&L Gates declined to comment directly on the layoffs, instead providing an explanation for the general reason for headcount reduction. The American Lawyer reported on…

Read More

Biden’s Drug Price Control Proposals Risk Stifling Medical Innovation, Says Chamber of Commerce Study

The U.S. Chamber of Commerce raised concerns Monday over the potential impact of the Biden administration’s proposed measures for controlling drug prices. A recent study released by the chamber, which analyzed clinical trial data, suggested that these measures could exert a chilling effect on medical innovation and lead to a significant drop in clinical trials….

Read More

Supreme Court Refuses to Hear Case on Abortion Clinic Bubble Zones, Upholding Restrictions on Protests

On Monday, the US Supreme Court decided not to consider a case that questioned the legality of ‘bubble’ zones around abortion clinics, thereby ensuring these areas will remain in place. These are designated spaces where anti-abortion protests are not permitted. The case in question involved Debra Vitagliano, a Catholic woman based in Westchester County, New…

Read More

Federal Judge Orders Eight-Year Ban on Migrant Family Separations Amid Reunification Settlement

A US federal judge has ordered an eight-year prohibition on the separation of migrant children from their families. This follows a recently approved settlement, dubbed the “Mrs. L” deal, that allows for reunification of migrant children and their families previously separated at the US-Mexico border. This legal victory comes as a result of a lawsuit…

Read More

Special Counsel Targets Trump’s Stall Tactics in Election Interference Case with Triple Court Blitz

Special Counsel Jack Smith has launched a stunning legal gambit against the dilatory tactics employed by former president Donald Trump in a bid to stall his election interference case until after the next election. Smith, in an unusual venture, has approached three separate courts pleading their intervention. Much of this legal drama was set in…

Read More

AR-15 Manufacturers Under Fire: Ethics, Morality, and Divine Condemnation Amidst Ongoing Gun Control Debate

In recent news, there appears to be a vast discussion tackling gun manufacturing and its moral implications, particularly involving manufacturers of the AR-15 rifle. Strong statements have even emerged suggesting the divine condemnation of such manufacturers due to the widespread violence associated with said weapon. This topic is not devoid of controversy, as the AR-15…

Read More

VLSI Maintains $949M Patent Infringement Win Despite Federal Circuit Ruling

On Monday, semiconductor firm VLSI Technology reassured a delighted Texas federal judge that a recent Federal Circuit ruling to nullify their hefty $2.2 billion patent infringement victory over Intel will not affect their additional $949 million judgement against the same company. This implies that the near-billion-dollar settlement still holds its weight and continues to be…

Read More

Sanofi Abandons Maze Therapeutics Deal Amid FTC Antitrust Scrutiny

In a recent move that exemplifies the ongoing legal oversight in large-scale pharmaceutical acquisitions, French multinational pharmaceutical company, Sanofi SA, has abandoned its plans to acquire an exclusive license for a treatment from Maze Therapeutics Inc. This decision comes on the heels of a contentious lawsuit filed by the Federal Trade Commission (FTC), who aimed…

Read More